
The meta-analysis of nine RCTs compared oral anticoagulants (OACs) and antiplatelets in preventing recurrent ischemic stroke in cryptogenic stroke or ESUS patients. OACs were more effective in patients with low-risk supracardiac atherosclerosis or atrial cardiopathy. There was no significant difference in overall stroke risk, but OACs were associated with a higher risk of major bleeding other than intracerebral hemorrhage.
Like
Save
Share